- Siemens AG
- Dade Behring Inc.
- Siemens Healthcare Diagnostics Inc.
- General Electric Co.
- GE Healthcare
- Siemens Medical Solutions USA Inc.
- Abbott Diagnostics
- Abbott Point of Care
- Abbott Laboratories Inc.
- Alere Inc.
- HemoSense Inc.
- Cholestech Corp.
- Biosite Inc.
- Quest Diagnostics Inc.
- AmeriPath Inc.
- Ventana Medical Systems Inc.
- Biacore International AB
- Isogenica Ltd.
- Pieris Pharmaceuticals Inc.
- Photocure ASA
- Eli Lilly & Co.
- Toshiba Corp.
- Philips Healthcare
- Mitsubishi Corp.
- Siemens acquires Diagnostic Products for $1.86bn
- Siemens buys Bayer Diagnostics for €4.2bn
- Siemens buys into clinical diagnostics in $7bn Dade takeover
- GE buys Abbott's POC, diagnostics units for $8bn; withdrawn
- Inverness is buying HemoSense for $171.6mm in stock
- Inverness Medical buys Cholestech for $299mm in stock
- Inverness Medical buys Biosite
- Quest to buy AmeriPath for $1.23bn
- GE Healthcare to acquire life sciences company Biacore
- Isogenica signs imaging deal with GE Healthcare
- Pieris and GE develop imaging compounds
- PhotoCure grants exclusive Hexvix rights to GE Healthcare; deal ends
- GE and Eli Lilly partner to develop Alzheimer's diagnostics
- GE Healthcare, Roche ally in Alzheimer's disease
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.